ArticleEMBO reports2026
Maternal microbiome promotes offspring ovarian reserve via bile acid metabolism.
Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
The maternal microbiome plays a crucial role in host ovarian function and fertility, yet its influence on in-utero ovarian development in offspring remains poorly understood. Here, we demonstrate that maternal antibiotic-induced microbiome disruption in mice leads to diminished ovarian reserve (DOR) in the offspring, while fecal microbiota transplantation (FMT) alleviates this effect. Metabolomic analysis reveals that maternal microbiome disruption alters metabolomic profiles in the maternal serum, with pathway enrichment analysis indicating reduced bile acid secretion in the maternal serum of ABX dams. Importantly, supplementation of key bile acid metabolites and transplantation of Lactobacillus gasseri (L. gasseri), a known promoter of bile acid metabolism, to antibiotic-treated dams abrogated maternal microbiome disruption-induced DOR. Additionally, through in vitro fertilization assay, we found that maternal microbiome disruption impaired oocyte quality in offspring, while FMT and supplementation with bile acid metabolites alleviated this effect. Together, our findings highlight the critical role of the maternal microbiome in offspring fertility, potentially through microbially mediated bile acid metabolism in the maternal serum.
Identifiers
42649273What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.